Study design of A phase 3, open-label trial for pozelimab and cemdisiran combination therapy in patients with paroxysmal nocturnal hemoglobinuria with inadequate control of intravascular hemolysis

Jang J. H., Lekue C. B., Burgues J. M. B., Calado R., Chang Y., Czyz J., ...More

67th Annual Meeting of the American-Society-of-Hematology (ASH), Florida, United States Of America, 6 - 09 December 2025, vol.146, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• Volume: 146
• Doi Number: 10.1182/blood-2025-4988
• City: Florida
• Country: United States Of America
• Istanbul University Affiliated: Yes